AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9467551
Drug: 1 ampoule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ampoule above the threshold dose of FSH
Trial: 9467551
Drug: Threshold dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Threshold dose of FSH
Trial: 8699040
Drug: Conventional intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional intravenous infusion of oxytocin
Trial: 2550167
Drug: Nadolol (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (240 mg per day, increased weekly for 4 weeks)
Trial: 2550167
Drug: Propranolol (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (240 mg per day, increased weekly for 4 weeks)
Trial: 6457170
Drug: ABPC (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABPC (2 g)
Trial: 30935548
Drug: Purslane cream
RxNorm normalized name: Purslane
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purslane cream (2% w/w)
Trial: 17767120
Drug: Lanolin ointment
RxNorm normalized name: Lanolin
DrugBank: Lanolin (DB11112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanolin ointment
Trial: 28734858
Drug: 5-grass pollen
RxNorm normalized name: grass pollen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-grass pollen tablet
Trial: 26098833
Drug: Jinlida (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jinlida (9 g) TID for 12 weeks
Trial: 7752258
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium carbonate (CaCO3) supplements (1.5 g) three times a day for 12 weeks
Trial: 1703920
Drug: Nitroglycerin tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin tape (5 mg) and ibopamine (100 mg)
Trial: 1703920
Drug: Nitroglycerin tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin tape (5 mg) and nifedipine (10 mg)
Trial: 23419134
Drug: Cediranib 20
RxNorm normalized name: cediranib
DrugBank: Cediranib (DB04849)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cediranib 20 mg orally daily
Trial: 23419134
Drug: Cediranib 20
RxNorm normalized name: cediranib
DrugBank: Cediranib (DB04849)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cediranib 20 mg orally daily + Prednisone 10 mg daily
Trial: 17942470
Drug: Sertraline for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline for 4 months
Trial: 15477504
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIg) treatment (2-g/kg loading dose, boosters of 0.4 g/kg every 6 weeks for 1 year)
Trial: 11825312
Drug: Inhibitors of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhibitors of platelet aggregation (including nitric oxide from L-arginine or glyceryl trinitrate) and anticoagulants (low molecular weight heparin, defibrotide)
Trial: 11825312
Drug: Intravenous infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusions of prostaglandins (PGs) PGE1 and PGI2
Trial: 11825312
Drug: Propionyl-L-carnitine and
RxNorm normalized name: glycine propionyl-L-carnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine and basic fibroblast growth factor (bFGF)
Trial: 8172381
Drug: Transdermal glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal glyceryl trinitrate (GTN) applied every eight hours until disappearance of inflammation signs.
Trial: 8172381
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment applied every eight hours until disappearance of inflammation signs.
Trial: 3278754
Drug: 13-cis retinoic
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 13-cis retinoic acid (13-CRA, 100 mg/m2)
Trial: 31925721
Drug: Pregabalin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150 mg daily)
Trial: 30128934
Drug: Leukocyte-poor platelet-rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukocyte-poor platelet-rich plasma (LP-PRP) injection
Trial: 28536030
Drug: Combination Hib-TT
RxNorm normalized name: TT 173
DrugBank: TT 173 (DB17717)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Hib-TT vaccine
Trial: 7118100
Drug: Part-time supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Part-time supportive treatment program
Trial: 16342005
Drug: Lithium administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium administration
Trial: 30399035
Drug: Lay worker
RxNorm normalized name: Apis cerana worker secretion preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lay worker administered combination intervention (individualized health education, retention/adherence support, appointment reminders, missed visit tracking)
Trial: 30463598
Drug: usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: usual care (medical treatment)
Trial: 20232572
Drug: Fexofenadine 120
RxNorm normalized name: fexofenadine hydrochloride 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine 120 mg daily
Trial: 17047171
Drug: hGH (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hGH (0.1 mg/kg/d for 3 weeks, then 0.1 mg/kg 3 days a week for 8 weeks)
Trial: 17047171
Drug: Placebo (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (subcutaneous saline)
Trial: 14609147
Drug: AAS administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AAS administration with resistance training
Trial: 3998786
Drug: Blood transfusions
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusions during definitive surgical therapy
Trial: 3998786
Drug: No blood
RxNorm normalized name: VivaGuard Ino Blood Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No blood transfusions during definitive surgical therapy
Trial: 3998786
Drug: Blood transfusions
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusions in patients receiving chemotherapy
Trial: 3998786
Drug: Blood transfusions
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusions in patients with large tumors (greater than 150 mL)
Trial: 26968881
Drug: Metronidazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (400 mg) plus penicillin (1,000,000 IU) for 10 days and 7 days respectively
Trial: 25362813
Drug: Imatynib-Biofarm 100
RxNorm normalized name: imatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatynib-Biofarm 100 mg film-coated tablet (test)
Trial: 25362813
Drug: Imatynib-Biofarm 400
RxNorm normalized name: imatinib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatynib-Biofarm 400 mg film-coated tablet (test)
Trial: 12021830
Drug: 12 g
RxNorm normalized name: PEG-12 GLYCERYL LAURATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 g oral glucose tablets
Trial: 10423646
Drug: 4 tablets
RxNorm normalized name: Ribasphere RibaPak 800, 4 Unit Dose Packs, 14 Tablets Each
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 tablets of potassium-magnesium citrate per day
Trial: 10423646
Drug: 7 tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 tablets of potassium-magnesium citrate per day
Trial: 10423646
Drug: 10 tablets
RxNorm normalized name: ALLANTOIN 0.11 in 600 mg VAGINAL TABLET [Jilgyungyi (10 Tablets)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 tablets of potassium-magnesium citrate per day
Trial: 6271386
Drug: High-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cyclophosphamide alone
Trial: 30949233
Drug: RG method
RxNorm normalized name: DNA, D((2'-O-(2-METHOXYETHYL))M5RC-SP-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-SP-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))RA-SP-T-SP-A-SP-M5C-SP-A-SP-T-SP-T-SP-T-SP-M5C-SP-T-SP-A-SP-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG method integrated in Flexible Assertive Community Treatment (FACT)
Trial: 24004959
Drug: Tocopheryl acetate
RxNorm normalized name: Tocopheryl acetate
DrugBank: alpha-Tocopherol acetate (DB14003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tocopheryl acetate 20% spray
Trial: 14646190
Drug: TACC-supplemented tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACC-supplemented tea (1.1 mg thiamin, 1240 mg arginine, 52 mg caffeine, 540 mg citric acid); n=16
Trial: 8096549
Drug: Denopamine 40
RxNorm normalized name: dopamine hydrochloride 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denopamine 40 mg/day
Trial: 3517554
Drug: Hydrocortisone (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (80 mg by mouth)
Trial: 29532075
Drug: 1.3 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3 g/kg/d of protein plus testosterone
Trial: 29532075
Drug: 1.3 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3 g/kg/d of protein plus placebo
Trial: 29532075
Drug: 0.8 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 g/kg/d of protein plus testosterone
Trial: 29532075
Drug: 0.8 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 g/kg/d of protein plus placebo
Trial: 21855173
Drug: E2 (estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 (estradiol patch)
Trial: 21855173
Drug: E2+CORT (estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2+CORT (estradiol patch/hydrocortisone)
Trial: 20973322
Drug: 0.0125% capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.0125% capsaicin gel applied three times daily for 4 weeks
Trial: 20973322
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel applied three times daily for 4 weeks
Trial: 18419724
Drug: 35 mg
RxNorm normalized name: papain 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg of 10 mg/ml isobaric 2-chloroprocaine
Trial: 18419724
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of 10 mg/ml isobaric 2-chloroprocaine
Trial: 18419724
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of 10 mg/ml isobaric 2-chloroprocaine
Trial: 11794431
Drug: Tibolone 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 1.25 mg once/day for 7 days
Trial: 11794431
Drug: Tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5 mg once/day for 7 days
Trial: 11794431
Drug: Tibolone 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 5.0 mg once/day for 7 days
Trial: 9724142
Drug: Long-term omeprazole
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term omeprazole treatment
Trial: 8040761
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) at a dosage of 0.5 U/kg per week (group 1: 4 boys, 3 girls)
Trial: 8040761
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) at a dosage of 1.0 U/kg per week (group 2: 6 boys, 2 girls)
Trial: 20837371
Drug: Atorvastatin up-titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin up-titration (40 mg to 80 mg or 20 mg to 40 mg)
Trial: 16181608
Drug: Individually tailored
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually tailored behavioral medicine treatment
Trial: 11468787
Drug: No previous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No previous treatment to eradicate the infection
Trial: 11468787
Drug: Previous eradication
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Previous eradication therapies
Trial: 9196518
Drug: BAYx 1005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAYx 1005 (500 mg twice daily)
Trial: 1436339
Drug: r‐HuEPO administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐HuEPO administered intravenously
Trial: 1436339
Drug: r‐HuEPO administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐HuEPO administered subcutaneously
Trial: 1436339
Drug: r‐HuEPO (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐HuEPO (both intravenous and subcutaneous)
Trial: 23945376
Drug: Artemisinin-combination therapy
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemisinin-combination therapy (ACT)
Trial: 21346060
Drug: GIN therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIN therapy (n = 49)
Trial: 19656386
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care support programme in primary care
Trial: 12666948
Drug: Braun Oral-B
RxNorm normalized name: bran Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral-B 3D Plaque Remover (three-dimensional oscillating/rotating/pulsating action)
Trial: 3309021
Drug: Maintenance cimetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maintenance cimetidine (400 mg at bedtime)
Trial: 22578110
Drug: NSAID (rofecoxib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID (rofecoxib 50 mg)
Trial: 20947859
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) at doses of 30-180 μg/kg over 3 days
Trial: 14712889
Drug: Topical brimonidine
RxNorm normalized name: brimonidine Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical brimonidine 0.2% b.d. (n = 90)
Trial: 14712889
Drug: Topical dorzolamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dorzolamide 2% b.d. (n=91)
Trial: 14712889
Drug: Topical latanoprost
RxNorm normalized name: Latanoprost
DrugBank: Latanoprost (DB00654)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Topical latanoprost 0.005% o.d. (n = 91)
Trial: 8877678
Drug: One transdermal
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One transdermal delivery system
Trial: 8877678
Drug: Two transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two transdermal delivery systems
Trial: 8877678
Drug: Three transdermal
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three transdermal delivery systems
Trial: 8877678
Drug: Two to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two to three transdermal delivery systems
Trial: 8877678
Drug: Standard recommended
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard recommended dose of two transdermal delivery systems
Trial: 1643987
Drug: Breast preservation
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast preservation therapy
Trial: 27635789
Drug: Low-dose CT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CT (120 kVp, 45 mAs)
Trial: 27554662
Drug: Standard-dose CT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose CT (120 kVp, 100 mAs)
Trial: 22927772
Drug: Pharmacogenetic-based warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacogenetic-based warfarin dosing algorithm (based on CYP2C9 and VKORC1 genotypes)
Trial: 18076560
Drug: Any anaemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any anaemia (haemoglobin < 11 g/dl)
Trial: 18076560
Drug: Moderate anaemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate anaemia (haemoglobin < 8 g/dl)
Trial: 8103876
Drug: Glucose-based ORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-based ORS solution
Trial: 3713254
Drug: 360 mg
RxNorm normalized name: aspirin 360 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 mg Mg/day (as magnesium citrate tablets)
Trial: 27494036
Drug: Sequential arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential arm (SA): induction cisplatin-5fluorouracil followed by 70Gy-RT for responders or total laryngectomy and post-operative RT for non-responders
Trial: 27494036
Drug: Alternating arm
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating arm (AA): cisplatin-5fluorouracil alternated with three 2-week courses of 20Gy-RT for a total dose of 60Gy
Trial: 23069788
Drug: Control subjects
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control subjects repeated the surgical procedure twice
Trial: 18765484
Drug: 10 mg/day
RxNorm normalized name: Adlarity 10 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/day of aripiprazole
Trial: 18765484
Drug: 30 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/day of aripiprazole
Trial: 31075675
Drug: In-vivo One-Session
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-vivo One-Session Treatment (OST)
Trial: 29606861
Drug: FF MDI
RxNorm normalized name: FF-10101-01
DrugBank: FF-10101-01 (DB16050)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF MDI 10 μg
Trial: 22790008
Drug: i.v. ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ketamine (bolus at induction, continuous infusion during surgery and first 48 hours postoperatively)
Trial: 22790008
Drug: i.v. placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. placebo (saline solution under the same infusion modalities)
Trial: 12040967
Drug: Pitavastatin 1
RxNorm normalized name: PITAVASTATIN 1MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 1 mg/day or more
Trial: 12040967
Drug: Pitavastatin 1
RxNorm normalized name: PITAVASTATIN 1MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 1 mg/day to 4 mg/day
Trial: 12799977
Drug: Low-energy shock-wave
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-energy shock-wave therapy (3000 impulses of 0.08 mJ/mm(2))
Trial: 1699337
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for pulmonary tuberculosis
Trial: 6451422
Drug: beta 2-Sympathomimetic
RxNorm normalized name: 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN
DrugBank: Hydroxypropyl betadex (DB15379)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta 2-Sympathomimetic drugs
Trial: 31040642
Drug: Choline alfoscerate
RxNorm normalized name: Choline Alfoscerate
DrugBank: Choline alfoscerate (DB04660)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline alfoscerate tablet (1,200 mg, 400 mg × three doses)
Trial: 31040642
Drug: Soft gelatin
RxNorm normalized name: Norvir Soft Gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft gelatin capsule (Gliatilin®) (1,200 mg, 400 mg × three doses)
Trial: 31040642
Drug: Choline alfoscerate
RxNorm normalized name: Choline Alfoscerate
DrugBank: Choline alfoscerate (DB04660)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline alfoscerate tablet vs Soft gelatin capsule
Trial: 25074771
Drug: Lutein 20
RxNorm normalized name: lutein 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein 20 mg/d
Trial: 25074771
Drug: Lutein 20
RxNorm normalized name: lutein 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein 20 mg/d (in patients with low plasma lutein)
Trial: 23182475
Drug: Deslorelin acetate
RxNorm normalized name: Deslorelin Acetate
DrugBank: Deslorelin (DB11510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deslorelin acetate (100 μg IM every 12h)
Trial: 12560148
Drug: Preparation book
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation book for surgery (experimental group)
Trial: 12560148
Drug: No preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preparation book (control group)
Trial: 10221357
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg propranolol hydrochloride
Trial: 27347553
Drug: Clinpro Tooth
RxNorm normalized name: sodium fluoride 0.950 mg in 1 g ORAL PASTE, DENTIFRICE [Clinpro Tooth Creme]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinpro Tooth Crème (brushing + additional topical application)
Trial: 22930148
Drug: Low-dose magnesium
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose magnesium sulphate (9 g loading dose: 4 g iv and 5 g im; maintenance 2.5 g im every 4 hours for 24 hours)
Trial: 22930148
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose magnesium sulphate (14 g loading dose; maintenance 5 g im every 4 hours)
Trial: 12917302
Drug: Cyclosporine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (3 mg per kilogram of body weight per day)
Trial: 31034251
Drug: PS-W (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PS-W (daily consumption of margarine containing 2 g/day of plant sterols with 30-min daily walking)
Trial: 31034251
Drug: C-S (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-S (daily consumption of control margarine while sedentary)
Trial: 31034251
Drug: PS-S (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PS-S (daily consumption of margarine containing 2 g/day of plant sterols while sedentary)